Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Graham

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
European Urology Oncology|January 20, 2026
Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumKosuke Takemura, Jeffrey Graham, David Maj, et al.
The Oncologist|August 4, 2025
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary Renal Cell CarcinomaManon De Vries-Brilland, Zineb Hamilou, Sunita Ghosh, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2022
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapyJeffrey Graham, John Connor Wells, Shaan Dudani, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis DatabaseChangsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2021
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021Christina Canil, Anil Kapoor, Naveen S Basappa, et al.
European Urology Oncology|August 15, 2019
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJeffrey Graham, J Connor Wells, Frede Donskov, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 12, 2019
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019Sebastien J Hotte, Anil Kapoor, Naveen S Basappa, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 5, 2024
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinomaJeffrey Graham, Ardalan E Ahmad, Naveen S Basappa, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic DiseasesCarrie Ye, Roko P A Nikolic, May Choi, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory ArthritidesCarrie Ye, Roko P A Nikolic, May Choi, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Urology Oncology|January 20, 2026
Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumKosuke Takemura, Jeffrey Graham, David Maj, et al.
The Oncologist|August 4, 2025
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary Renal Cell CarcinomaManon De Vries-Brilland, Zineb Hamilou, Sunita Ghosh, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2022
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapyJeffrey Graham, John Connor Wells, Shaan Dudani, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis DatabaseChangsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2021
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021Christina Canil, Anil Kapoor, Naveen S Basappa, et al.
European Urology Oncology|August 15, 2019
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJeffrey Graham, J Connor Wells, Frede Donskov, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 12, 2019
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019Sebastien J Hotte, Anil Kapoor, Naveen S Basappa, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 5, 2024
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinomaJeffrey Graham, Ardalan E Ahmad, Naveen S Basappa, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic DiseasesCarrie Ye, Roko P A Nikolic, May Choi, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory ArthritidesCarrie Ye, Roko P A Nikolic, May Choi, et al.
Pageof 6